Biotech Stock With Covid Solution Offering 'A Huge Potential'
9,675 views
0

 Published On Aug 25, 2020

Biotech stocks are always risky and in this video, using the example of Marinomed Biotech stock that is working with nasal spays, not profitable and really small, I wish to explain the risks and rewards of investing in such companies.
I understand the hopes that can be created when a management promises scaling, growth, high margins and a cure to some disease, but then again burning twice as much cash as you make in revenue should be a thing to take into consideration.
There are many words that are often used with stocks that promise a lot, so be sure to check the facts really good before investing. Your best friend is Google and look for confirmations on what is the management selling.
So, when it comes to biotech stock prices, it all depends on whether the product will ever get traction. However, a market cap of 136 million EUR on 5 million of sea weed sales is remarkable!

Are you a sophisticated investor looking for in depth, independent stock analyses for investing ideas?Here is my independent stock market analysis and research! STOCK MARKET RESEARCH PLATFORM (analysis, stocks to buy, model portfolio)

https://sven-carlin-research-platform...

Are you an investor that is just starting? Sign up for the FREE Stock Market Investing Course - a comprehensive guide to investing discussing all that matters: https://sven-carlin-research-platform...

I am also a book author:
Modern Value Investing book:
https://amzn.to/2lvfH3t

Check my website to hear more about me, read my analyses and about OUR charity. (YouTube ad money is donated)
www.svencarlin.com

Listen to Modern Value Investing Podcast:
https://svencarlin.com/podcasts/

#stocks #covidstocks

show more

Share/Embed